T-group (topology)
2007.15.1 N-deoxyribosyltransferase
Ligands and drugs
581
Member domains
351
with ligand contacts (≤ 4 Å)
60.4% of members
277
with DrugDomain annotations
47.7% of members
143
with a DrugBank compound
24.6% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2007.15.1 belongs to X-group 2007 Flavodoxin-like, which binds 8.9 ligand superclasses per 20 proteins, broader than 77% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02701 | NCA | Nicotinamide | 17 |
| DB03227 | NMN | Nicotinamide Mononucleotide | 9 |
| DB14128 | NAD | Nadide | 9 |
| DB03846 | 5HU | 2'-deoxy-5-(hydroxymethyl)uridine 5'-(dihydrogen phosphate) | 6 |
| DB00141 | NAG | N-Acetylglucosamine | 4 |
| DB07205 | 6IA | N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE | 4 |
| DB14636 | TR5 | Triciribine phosphate | 4 |
| DB00173 | ADE | Adenine | 3 |
| DB02168 | BP1 | 6-bromopurine | 3 |
| DB02753 | SNI | Selenoinosine | 3 |
| DB04137 | GTP | Guanosine-5'-Triphosphate | 3 |
| DB01972 | 5GP | Guanosine-5'-Monophosphate | 2 |
| DB02930 | AGS | Adenosine 5'-[gamma-thio]triphosphate | 2 |
| DB03403 | C5P | Cytidine-5'-Monophosphate | 2 |
| DB03732 | ENP | Etheno-Nadp | 2 |
| DB03763 | 5MD | 5-methyl-2'-deoxypseudouridine | 2 |
| DB03800 | UMP | Deoxyuridine monophosphate | 2 |
| DB04145 | PYF | Nicotinyl alcohol | 2 |
| DB04580 | 12Q | 1-Methyl-2-quinolone | 2 |
| DB04605 | 5IQ | 5-Aminoisoquinoline | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| AVU | [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl[(2R,3R,4R)-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl dihydrogen diphosphate | 34 |
| CL | CHLORIDE ION | 27 |
| NCA | NICOTINAMIDE | 17 |
| AV1 | [(2R,3S,4R,5R)-5-(6-amino-8-bromo-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl [(2R,3S,4S)-3,4-dihydroxytetrahydrofuran-2-yl]methyl dihydrogen diphosphate | 15 |
| N | ANY 5'-MONOPHOSPHATE NUCLEOTIDE | 11 |
| 5HU | 5-HYDROXYMETHYLURIDINE-2'-DEOXY-5'-MONOPHOSPHATE | 9 |
| NAD | NICOTINAMIDE-ADENINE-DINUCLEOTIDE | 9 |
| NMN | BETA-NICOTINAMIDE RIBOSE MONOPHOSPHATE | 9 |
| 6C6 | N-cyclopentyladenosine 5'-(dihydrogen phosphate) | 8 |
| CXR | CYCLIC ADENOSINE DIPHOSPHATE-RIBOSE | 8 |
| RF5 | 2-deoxy-2-fluoro-5-O-phosphono-alpha-D-arabinofuranose | 8 |
| RIB | alpha-D-ribofuranose | 8 |
| G2Q | GUANOSINE DIPHOSPHATE RIBOSE | 6 |
| AVW | [(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl [(2R,3R,4S)-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl dihydrogen diphosphate | 5 |
| 2DR | 2-deoxy-beta-D-erythro-pentofuranose | 4 |
| 6IA | N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE | 4 |
| 6K6 | N-(furan-2-ylmethyl)adenosine 5'-(dihydrogen phosphate) | 4 |
| A1H0F | (2~{R},3~{R})-4,4-bis(fluoranyl)-2-(hydroxymethyl)oxolan-3-ol | 4 |
| A1I1M | 2-[1-methyl-5-[[1-[2-(methylamino)phenyl]carbonylpiperidin-4-yl]amino]-1,2,4-triazol-3-yl]-1~{H}-indole-6-carbonitrile | 4 |
| A1I1U | 8-[3-(6-cyano-1~{H}-indol-2-yl)-5-[[1-[2-(methylamino)phenyl]carbonylpiperidin-4-yl]amino]-1,2,4-triazol-1-yl]octanoic acid | 4 |